Platinum (Pt)-based chemotherapeutics is emerging as a promising strategy for cancer treatment in clinical trials. Protein O-linked β-N-acetylglucosamine (O-GlcNAc) modification has been reported to occur on several important proteins implicated in regulating cancer resistance to Pt drugs. However, ...
ORGANISM(S): Homo sapiens (Human)
